Treatment of silent acid reflux does not improve asthma in children, NIH study finds

( NIH/National Heart, Lung and Blood Institute ) Adding the acid reflux drug lansoprazole to a standard inhaled steroid treatment for asthma does not improve asthma control in children who have no symptom of acid reflux, according to a new study funded in part by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health. Lansoprazole therapy slightly increased the ...

Treatment of silent acid reflux does not improve asthma in children, study finds

Adding the acid reflux drug lansoprazole to a standard inhaled steroid treatment for asthma does not improve asthma control in children who have no symptom of acid reflux, according to a new study. Lansoprazole therapy slightly increased the risk of sore throats and other respiratory problems in children, however.

Adding proton pump inhibitor to treat poorly controlled asthma in children does not improve symptoms

Children without symptoms of gastroesophageal reflux whose asthma was being poorly controlled with anti-inflammatory treatment did not have an improvement in symptoms or lung function with the added treatment of the proton pump inhibitor lansoprazole, compared to patients who received placebo, according to a study in the Jan. 25 issue of JAMA. Use of lansoprazole was associated with increased ...

Acid reflux drug does not improve asthma in children

Children without symptoms of gastroesophageal reflux whose asthma was being poorly controlled with anti-inflammatory treatment did not have an improvement in symptoms or lung function with the added treatment of the proton pump inhibitor lansoprazole, compared to patients who received placebo, according to a study in the January 25 issue of JAMA. Use of lansoprazole was associated with increased ...

Addition of proton pump inhibitor to treatment of poorly controlled asthma in children does not improve symptoms

Children without symptoms of gastroesophageal reflux whose asthma was being poorly controlled with anti-inflammatory treatment did not have an improvement in symptoms or lung function with the added treatment of the proton pump inhibitor lansoprazole, compared to patients who received placebo, according to a new study. Use of lansoprazole was associated with increased adverse events.